Goldman Sachs reposted this
On June 17, Caris Life Sciences successfully priced its $568M IPO. Caris is a precision medicine leader with comprehensive molecular profiling and advanced artificial intelligence capabilities. We are honored to have served as joint lead bookrunner.
Congrats! 🎉
Well done!
💪🌎❤️
Well done!
Congratulations to Caris Life Sciences on this milestone! Exciting to see advancements in precision medicine.
Impressive work
👍👏
Congratulations on such advancements and accomplishments in medicine.
Well done!
Bsc Research (Economics and Finance) at Shiv Nadar University
1dIncredible to see this come together — a $568M IPO in a space as nuanced as precision medicine is no small feat. Caris’ positioning at the intersection of molecular profiling and AI makes it a particularly compelling story, but it still takes real finesse to guide that narrative into the public markets effectively. Hats off to the team at GS for helping drive what looks like a very well-executed pricing and debut. Definitely one to watch in the biotech IPO space this year.